HCA Holdings, Inc. (NYSE:HCA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday.

According to Zacks, “HCA Healthcare’s   shares have outperformed the industry year to date. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. During the second quarter results the company reported earnings of  $1.77 per share which lagged estimates by 1.7% but were up 5.4% year over year. The earnings miss can be traced back to an increase in expenses, which outpaced revenue growth. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts  and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance.”

Several other equities research analysts also recently issued reports on the company. BidaskClub downgraded HCA Holdings from a “sell” rating to a “strong sell” rating in a research note on Saturday. Citigroup Inc. reduced their price objective on HCA Holdings from $89.00 to $87.00 and set a “neutral” rating for the company in a research note on Wednesday, July 26th. Morgan Stanley reissued an “equal weight” rating and issued a $88.00 price objective (down from $90.00) on shares of HCA Holdings in a research note on Wednesday, July 26th. Bank of America Corporation downgraded HCA Holdings from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $102.00 to $92.00 in a research note on Wednesday, July 26th. Finally, Argus began coverage on HCA Holdings in a research note on Wednesday, June 28th. They issued a “buy” rating and a $100.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company. HCA Holdings presently has an average rating of “Buy” and a consensus price target of $93.50.

HCA Holdings (HCA) traded up 0.0817% during mid-day trading on Tuesday, reaching $78.5541. The company’s stock had a trading volume of 1,716,933 shares. The firm has a market capitalization of $29.48 billion, a price-to-earnings ratio of 10.5300 and a beta of 0.67. The firm has a 50-day moving average of $84.93 and a 200 day moving average of $84.50. HCA Holdings has a 1-year low of $67.00 and a 1-year high of $91.03.

HCA Holdings (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.80 by $0.05. The business had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.66 earnings per share. Equities analysts expect that HCA Holdings will post $7.20 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/08/hca-holdings-inc-nysehca-stock-rating-upgraded-by-zacks-investment-research.html.

In other HCA Holdings news, insider Jonathan B. Perlin sold 71,063 shares of the firm’s stock in a transaction that occurred on Thursday, June 22nd. The stock was sold at an average price of $86.00, for a total value of $6,111,418.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $84.52, for a total value of $181,718.00. Following the completion of the sale, the insider now directly owns 12,254 shares in the company, valued at approximately $1,035,708.08. The disclosure for this sale can be found here. In the last three months, insiders have sold 151,424 shares of company stock worth $12,787,290. 2.90% of the stock is currently owned by insiders.

Hedge funds have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC raised its stake in HCA Holdings by 0.4% in the second quarter. Janney Montgomery Scott LLC now owns 3,174 shares of the company’s stock worth $277,000 after buying an additional 14 shares during the period. Advisor Partners LLC raised its stake in HCA Holdings by 0.3% in the second quarter. Advisor Partners LLC now owns 4,732 shares of the company’s stock worth $413,000 after buying an additional 14 shares during the period. Wetherby Asset Management Inc. raised its stake in HCA Holdings by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 4,232 shares of the company’s stock worth $369,000 after buying an additional 25 shares during the period. Boston Advisors LLC raised its stake in HCA Holdings by 0.6% in the first quarter. Boston Advisors LLC now owns 6,212 shares of the company’s stock worth $553,000 after buying an additional 37 shares during the period. Finally, Capstone Asset Management Co. raised its stake in HCA Holdings by 1.1% in the first quarter. Capstone Asset Management Co. now owns 7,083 shares of the company’s stock worth $630,000 after buying an additional 80 shares during the period. 74.54% of the stock is currently owned by hedge funds and other institutional investors.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Holdings (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.